Mercy Hospital Booneville
Mercy Hospital Booneville was paid $1.31M by Medicaid between Jan 2018 and Dec 2024, across 88 billing codes. Its largest line is 80053, Comprehensive metabolic panel — 13% of everything it billed.
BOONEVILLE, AR 72927
Next to other Surgery Physician providers in Arkansas
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,453 | $211K | |
| 2019 | 13,798 | $226K | |
| 2020 | 11,347 | $192K | |
| 2021 | 8,735 | $177K | |
| 2022 | 8,050 | $190K | |
| 2023 | 7,554 | $170K | |
| 2024incomplete | 6,327 | $147K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80053 | Comprehensive metabolic panel | 13% | 6,405 | 5,591 | $171K |
| 70450 | Computed tomography, head or brain; without contrast material | 12% | 1,066 | 957 | $161K |
| 87428 | 8.8% | 1,921 | 1,836 | $115K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 5.7% | 1,759 | 472 | $76K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.3% | 8,333 | 7,041 | $69K |
| 84484 | 5.0% | 1,914 | 1,595 | $66K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 4.1% | 4,509 | 4,310 | $54K |
| 71046 | Radiologic examination, chest; 2 views | 4.0% | 2,499 | 2,280 | $53K |
| 36415 | Collection of venous blood by venipuncture | 3.9% | 3,810 | 3,009 | $52K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.8% | 2,222 | 2,072 | $50K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.7% | 176 | 167 | $35K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.5% | 2,226 | 1,865 | $33K |
76 more codes
| 80048 | Basic metabolic panel (calcium, ionized) | 2.5% | 1,462 | $33K |
| 80050 | General health panel | 2.0% | 645 | $26K |
| 80306 | 1.8% | 1,105 | $24K | |
| 71045 | Radiologic examination, chest; single view | 1.7% | 1,817 | $22K |
| 83880 | 1.7% | 906 | $22K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.4% | 523 | $18K |
| 83605 | 1.4% | 772 | $18K | |
| 83690 | 1.1% | 1,029 | $14K | |
| 80061 | Lipid panel | 1.0% | 1,577 | $13K |
| 81025 | 1.0% | 1,355 | $13K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 136 | $13K |
| 83735 | <1% | 1,279 | $12K | |
| 81003 | <1% | 2,432 | $10K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 167 | $10K |
| 81001 | <1% | 2,243 | $10K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,064 | $9K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 186 | $9K |
| 99285 | Emergency room visit (most serious) | <1% | 522 | $8K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 864 | $7K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,049 | $6K |
| 85610 | <1% | 1,282 | $6K | |
| 87081 | <1% | 629 | $6K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 78 | $5K |
| 87807 | <1% | 443 | $5K | |
| 85730 | <1% | 543 | $4K | |
| 87400 | <1% | 330 | $4K | |
| 99284 | Emergency room visit (serious) | <1% | 107 | $4K |
| 84439 | <1% | 465 | $3K | |
| 80164 | <1% | 493 | $3K | |
| 73630 | <1% | 79 | $3K | |
| 73562 | <1% | 66 | $3K | |
| 82962 | <1% | 210 | $2K | |
| 71020 | <1% | 167 | $2K | |
| 87077 | <1% | 257 | $2K | |
| 99283 | Emergency room visit (moderate) | <1% | 52 | $2K |
| 87040 | <1% | 121 | $2K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 25 | $2K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 354 | $2K |
| 73610 | <1% | 80 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 830 | $2K |
| 87186 | <1% | 235 | $1K | |
| 87420 | <1% | 107 | $1K | |
| 82553 | <1% | 62 | $1K | |
| 82550 | <1% | 87 | $1K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 25 | $1K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 15 | $1K |
| 87430 | <1% | 71 | $974.50 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 604 | $821.40 |
| 73030 | <1% | 15 | $699.65 | |
| 74022 | <1% | 20 | $697.78 | |
| 82947 | <1% | 35 | $676.93 | |
| 82077 | <1% | 27 | $544.98 | |
| 72100 | <1% | 12 | $480.56 | |
| 74018 | <1% | 15 | $414.31 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 322 | $335.88 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 763 | $323.31 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 19 | $295.89 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 446 | $288.08 |
| 82805 | <1% | 13 | $287.27 | |
| 73110 | <1% | 13 | $266.00 | |
| 82607 | <1% | 27 | $258.24 | |
| 87147 | <1% | 25 | $253.26 | |
| 71010 | <1% | 27 | $198.00 | |
| 87088 | <1% | 31 | $189.24 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 120 | $150.24 |
| 86140 | <1% | 19 | $131.12 | |
| 87070 | <1% | 14 | $126.32 | |
| 82570 | <1% | 44 | $112.85 | |
| 87205 | <1% | 26 | $103.85 | |
| 85651 | <1% | 34 | $81.12 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 218 | $72.83 |
| 82043 | <1% | 28 | $66.16 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 32 | $10.98 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 16 | $10.85 |
| A9270 | Non-covered item or service | <1% | 97 | $7.70 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Mercy Hospital Carthage | Carthage, MO | $18.78M |
| Mercy Hospital Aurora | Aurora, MO | $9.91M |
| Mercy Hospital Cassville | Cassville, MO | $9.56M |
| Mercy Hospital Logan County INC | Guthrie, OK | $5.02M |
| Mercy Hospital Berryville | Berryville, AR | $2.86M |
| Mercy Hospital Healdton, INC. | Healdton, OK | $1.45M |
| Mercy Hospital Watonga INC | Watonga, OK | $1.17M |
| Mercy Hospital Waldron | Waldron, AR | $1.17M |
| Mercy Hospital Perry | Perryville, MO | $1.05M |
| Mercy Hospital Logan County, INC | Guthrie, OK | $924K |
| Mercy Hospital Ozark | Ozark, AR | $839K |
| Mercy Hospital Paris | Paris, AR | $834K |
| Mercy Hospital Carthage | Carthage, MO | $788K |
| Mercy Hospital Kingfisher, INC | Kingfisher, OK | $385K |
| Mercy Hospital Paris | Paris, AR | $363K |
| Mercy Hospital Ozark | Ozark, AR | $268K |
| Mercy Hospital Booneville | Booneville, AR | $200K |
| Mercy Hospital Paris | Paris, AR | $152K |
| Mercy Hospital Waldron | Waldron, AR | $150K |
| Mercy Hospital Perry | Perryville, MO | $131K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.